Menu Icon Created with Sketch Beta.

Early Cancer Detection

Thrive Earlier Detection

Previous Post Left arrow Next Post Right Arrow

Thrive Earlier Detection envisions a future in which blood drawn at an annual physical is used to find early-stage cancer. Exact Sciences acquired Thrive for up to $2.15B in 2021.

Thrive combines cutting-edge liquid biopsy technology with a machine learning engine to find multiple cancer types from a single blood draw — including many cancers that lack effective screening tools such as ovarian, pancreatic, liver cancers and others.

View All Companies